Company / FCF Margin
InMed Pharmaceuticals Inc. FCF Margin History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-152.1%
FY2025
5-year range
-1434.0% / -152.1%
FY2022-FY2025
Trend
+15.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -1434.0% to -152.1% over the past 2 years.
Based on SEC 10-K filings.
-152.1% in FY2025 with a 3-year CAGR of +746.7%.
Improved from -1434.0% to -152.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +746.7pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 15.5% year-over-year.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -152.1% | +15.5% |
| FY2024 | -180.0% | +87.4% |
| FY2023 | -1434.0% | -59.5% |
| FY2022 | -898.9% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026